Kewaunee Scientific Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Revenue	282	240.47	203.76	219.49	168.87
Revenue Growth	17.27%	18.02%	-7.17%	29.98%	14.51%
Cost of Revenue	201.56	171.62	151.7	183.91	144.65
Gross Profit	80.44	68.86	52.05	35.59	24.22
Selling, General & Admin	63.73	51.1	33.77	30.22	26.83
Total Operating Expenses	63.73	51.1	33.77	30.22	26.83
Operating Income	16.72	17.76	18.28	5.36	-2.61
Interest Expense	-3.86	-3.21	-1.8	-1.73	-0.63
Other Non-Operating Income (Expense)	0.88	0.24	-3.36	0.87	0.76
Total Non-Operating Income (Expense)	-2.98	-2.97	-5.16	-0.87	0.12
Pretax Income	13.73	14.79	13.12	4.5	-2.49
Provision for Income Taxes	3.27	3.2	-5.94	3.14	3.52
Net Income	10.47	11.58	19.06	1.36	-6
Minority Interest in Earnings	0.85	0.18	0.3	0.62	0.12
Net Income to Common	9.62	11.41	18.75	0.74	-6.13
Net Income Growth	-15.67%	-39.18%	2441.06%	-	-
Shares Outstanding (Basic)	3	3	3	3	3
Shares Outstanding (Diluted)	3	3	3	3	3
Shares Change	0.13%	1.40%	1.24%	4.16%	0.94%
EPS (Basic)	3.36	3.98	6.51	0.26	-2.20
EPS (Diluted)	3.22	3.83	6.38	0.25	-2.20
EPS Growth	-15.93%	-39.97%	2452.00%	-	-
Free Cash Flow	14.7	12.62	15.19	-7.94	-9.79
Free Cash Flow Growth	16.48%	-16.94%	-	-	-
Free Cash Flow Per Share	4.93	4.24	5.17	-2.74	-3.52
Gross Margin	28.52%	28.63%	25.55%	16.21%	14.34%
Operating Margin	5.93%	7.39%	8.97%	2.44%	-1.54%
Profit Margin	3.71%	4.82%	9.35%	0.62%	-3.55%
FCF Margin	5.21%	5.25%	7.46%	-3.62%	-5.80%
EBITDA	23	22.52	21.41	8.23	0.16
EBITDA Margin	8.15%	9.36%	10.51%	3.75%	0.10%
EBIT	16.72	17.76	18.28	5.36	-2.61
EBIT Margin	5.93%	7.39%	8.97%	2.44%	-1.54%
Effective Tax Rate	23.80%	21.66%	-45.26%	69.79%	-141.57%

SEC Filings: 10-K · 10-Q